Aman, Jay-ar A.

HRN: 11-30-36  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2023
CEFUROXIME 1.5GM (VIAL)
02/17/2023
02/24/2023
IVTT
900mg
Q8
URTI
Waiting Final Action 
02/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/19/2023
02/26/2023
IV
230 Mg
Q8
Intestinal Amoebiasis
Waiting Final Action 
02/20/2023
CEFTRIAXONE 1G (VIAL)
02/20/2023
02/26/2023
IV
2g
Q24
PCAP
Waiting Final Action 
02/20/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
02/20/2023
02/26/2023
ORAL
15ML
TID
AMOEBIASIS
Waiting Final Action 
02/23/2023
AMOXICILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
02/23/2023
03/09/2023
PO
6 Ml
TID
H. Pylori
Waiting Final Action 
02/23/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
02/23/2023
03/09/2023
PO
11 Ml
BID
H. Pylori
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: